The U.S. Food and Drug Administration (FDA) has announced the approval of Qfitlia (fitusiran), a treatment designed to ...
Data from the ATLAS research comprises a series of trials that have yielded years of long-term, comprehensive data on safety ...
The current state of treatment for geographic atrophy is marked by two approved therapies that slow GA progression: ...
Mural Oncology's stock plummeted 57% after halting the Phase 3 ARTISTRY-7 trial for nemvaleukin alfa. Click here to read an ...
Pharmaceutical Technology on MSN5d
Soleno wins FDA approval for Prader-Willi hyperphagia treatmentSoleno Therapeutics has won US Food and Drug Administration (FDA) approval for diazoxide choline – which will be branded as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback